DRAEGERWERK AG (DRW8.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:DRW8 - DE0005550602 - Common Stock
56.4 EUR
-0.4 (-0.7%)
Taking everything into account, DRW8 scores 5 out of 10 in our fundamental rating. DRW8 was compared to 62 industry peers in the Health Care Equipment & Supplies industry. DRW8 has only an average score on both its financial health and profitability. DRW8 scores decently on growth, while it is valued quite cheap. This could make an interesting combination. DRW8 also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
DRW8 had positive earnings in the past year.
DRW8 had a positive operating cash flow in the past year.
Of the past 5 years DRW8 4 years were profitable.
Of the past 5 years DRW8 4 years had a positive operating cash flow.
1.2 Ratios
DRW8 has a Return On Assets (3.99%) which is comparable to the rest of the industry.
DRW8 has a Return On Equity (8.02%) which is in line with its industry peers.
DRW8 has a better Return On Invested Capital (7.67%) than 66.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.99% | ||
| ROE | 8.02% | ||
| ROIC | 7.67% |
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
DRW8's Profit Margin of 3.54% is in line compared to the rest of the industry. DRW8 outperforms 45.16% of its industry peers.
DRW8's Profit Margin has improved in the last couple of years.
DRW8 has a Operating Margin (6.02%) which is comparable to the rest of the industry.
DRW8's Operating Margin has improved in the last couple of years.
DRW8 has a worse Gross Margin (45.35%) than 66.13% of its industry peers.
DRW8's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.02% | ||
| PM (TTM) | 3.54% | ||
| GM | 45.35% |
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so DRW8 is still creating some value.
DRW8 has less shares outstanding than it did 1 year ago.
DRW8 has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, DRW8 has an improved debt to assets ratio.
2.2 Solvency
DRW8 has an Altman-Z score of 2.63. This is not the best score and indicates that DRW8 is in the grey zone with still only limited risk for bankruptcy at the moment.
DRW8's Altman-Z score of 2.63 is in line compared to the rest of the industry. DRW8 outperforms 56.45% of its industry peers.
The Debt to FCF ratio of DRW8 is 2.16, which is a good value as it means it would take DRW8, 2.16 years of fcf income to pay off all of its debts.
DRW8 has a Debt to FCF ratio of 2.16. This is in the better half of the industry: DRW8 outperforms 77.42% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that DRW8 is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.10, DRW8 is in the better half of the industry, outperforming 75.81% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 2.16 | ||
| Altman-Z | 2.63 |
ROIC/WACC1.18
WACC6.49%
2.3 Liquidity
A Current Ratio of 1.76 indicates that DRW8 should not have too much problems paying its short term obligations.
DRW8 has a Current ratio (1.76) which is in line with its industry peers.
DRW8 has a Quick Ratio of 1.03. This is a normal value and indicates that DRW8 is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.03, DRW8 perfoms like the industry average, outperforming 45.16% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.03 |
3. Growth
3.1 Past
DRW8 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.68%.
Measured over the past years, DRW8 shows a very strong growth in Earnings Per Share. The EPS has been growing by 36.42% on average per year.
Looking at the last year, DRW8 shows a small growth in Revenue. The Revenue has grown by 2.14% in the last year.
Measured over the past years, DRW8 shows a small growth in Revenue. The Revenue has been growing by 3.92% on average per year.
EPS 1Y (TTM)6.68%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%143.82%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%7.58%
3.2 Future
Based on estimates for the next years, DRW8 will show a small growth in Earnings Per Share. The EPS will grow by 7.93% on average per year.
DRW8 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.15% yearly.
EPS Next Y5.38%
EPS Next 2Y11.08%
EPS Next 3Y11.69%
EPS Next 5Y7.93%
Revenue Next Year2.84%
Revenue Next 2Y3.51%
Revenue Next 3Y3.67%
Revenue Next 5Y3.15%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
DRW8 is valuated reasonably with a Price/Earnings ratio of 8.74.
Based on the Price/Earnings ratio, DRW8 is valued cheaply inside the industry as 98.39% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of DRW8 to the average of the S&P500 Index (26.51), we can say DRW8 is valued rather cheaply.
With a Price/Forward Earnings ratio of 7.69, the valuation of DRW8 can be described as very cheap.
93.55% of the companies in the same industry are more expensive than DRW8, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.13. DRW8 is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.74 | ||
| Fwd PE | 7.69 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DRW8 is valued cheaper than 96.77% of the companies in the same industry.
96.77% of the companies in the same industry are more expensive than DRW8, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.73 | ||
| EV/EBITDA | 3.09 |
4.3 Compensation for Growth
DRW8's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.63
PEG (5Y)0.24
EPS Next 2Y11.08%
EPS Next 3Y11.69%
5. Dividend
5.1 Amount
DRW8 has a Yearly Dividend Yield of 3.46%.
DRW8's Dividend Yield is rather good when compared to the industry average which is at 1.11. DRW8 pays more dividend than 91.94% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.00, DRW8 pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.46% |
5.2 History
The dividend of DRW8 is nicely growing with an annual growth rate of 51.02%!
Dividend Growth(5Y)51.02%
Div Incr Years2
Div Non Decr Years4
5.3 Sustainability
31.13% of the earnings are spent on dividend by DRW8. This is a low number and sustainable payout ratio.
The dividend of DRW8 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP31.13%
EPS Next 2Y11.08%
EPS Next 3Y11.69%
FRA:DRW8 (12/30/2025, 7:00:00 PM)
56.4
-0.4 (-0.7%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners10.23%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.06B
Revenue(TTM)3.42B
Net Income(TTM)120.88M
Analysts81.33
Price Target82.49 (46.26%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.46% |
Yearly Dividend1.77
Dividend Growth(5Y)51.02%
DP31.13%
Div Incr Years2
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)11.47%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.26%
EPS NY rev (3m)2.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)0.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.74 | ||
| Fwd PE | 7.69 | ||
| P/S | 0.31 | ||
| P/FCF | 7.73 | ||
| P/OCF | 5.21 | ||
| P/B | 0.7 | ||
| P/tB | 0.91 | ||
| EV/EBITDA | 3.09 |
EPS(TTM)6.45
EY11.44%
EPS(NY)7.34
Fwd EY13.01%
FCF(TTM)7.29
FCFY12.93%
OCF(TTM)10.82
OCFY19.18%
SpS182.27
BVpS80.37
TBVpS62.21
PEG (NY)1.63
PEG (5Y)0.24
Graham Number108
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.99% | ||
| ROE | 8.02% | ||
| ROCE | 10.2% | ||
| ROIC | 7.67% | ||
| ROICexc | 8.64% | ||
| ROICexgc | 10.67% | ||
| OM | 6.02% | ||
| PM (TTM) | 3.54% | ||
| GM | 45.35% | ||
| FCFM | 4% |
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-18.01%
ROICexgc growth 5Y12.44%
ROICexc growth 3Y-16.98%
ROICexc growth 5Y13.06%
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
F-Score7
Asset Turnover1.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 2.16 | ||
| Debt/EBITDA | 0.44 | ||
| Cap/Depr | 44.92% | ||
| Cap/Sales | 1.93% | ||
| Interest Coverage | 11.48 | ||
| Cash Conversion | 57.51% | ||
| Profit Quality | 113.22% | ||
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.03 | ||
| Altman-Z | 2.63 |
F-Score7
WACC6.49%
ROIC/WACC1.18
Cap/Depr(3y)46.64%
Cap/Depr(5y)59.31%
Cap/Sales(3y)2.11%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.68%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%143.82%
EPS Next Y5.38%
EPS Next 2Y11.08%
EPS Next 3Y11.69%
EPS Next 5Y7.93%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%7.58%
Revenue Next Year2.84%
Revenue Next 2Y3.51%
Revenue Next 3Y3.67%
Revenue Next 5Y3.15%
EBIT growth 1Y12.74%
EBIT growth 3Y-13.63%
EBIT growth 5Y16.27%
EBIT Next Year83.49%
EBIT Next 3Y27.99%
EBIT Next 5Y13.46%
FCF growth 1Y20.52%
FCF growth 3Y-27.65%
FCF growth 5Y0.28%
OCF growth 1Y11.8%
OCF growth 3Y-24.25%
OCF growth 5Y0.35%
DRAEGERWERK AG / DRW8.DE FAQ
Can you provide the ChartMill fundamental rating for DRAEGERWERK AG?
ChartMill assigns a fundamental rating of 5 / 10 to DRW8.DE.
What is the valuation status of DRAEGERWERK AG (DRW8.DE) stock?
ChartMill assigns a valuation rating of 7 / 10 to DRAEGERWERK AG (DRW8.DE). This can be considered as Undervalued.
What is the profitability of DRW8 stock?
DRAEGERWERK AG (DRW8.DE) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for DRW8 stock?
The Price/Earnings (PE) ratio for DRAEGERWERK AG (DRW8.DE) is 8.74 and the Price/Book (PB) ratio is 0.7.
What is the expected EPS growth for DRAEGERWERK AG (DRW8.DE) stock?
The Earnings per Share (EPS) of DRAEGERWERK AG (DRW8.DE) is expected to grow by 5.38% in the next year.